Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health Corp    CVS

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Court Rules Two CVS Florida Pharmacies Can't Ship Pain Pills

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/22/2012 | 11:59pm CET
   By John Kell 
   Of  
 

A U.S. appeals court said two CVS Caremark Corp. (>> CVS Caremark Corporation) pharmacies in Florida cannot fill prescriptions for certain controlled drugs related to a Drug Enforcement Administration move to halt such sales.

The decision lifted a temporary, administrative stay that was granted to CVS earlier this month, at the time allowing the pharmacies to keep dispensing controlled medications after an appeals court denied the chain's request for preliminary injunction.

The case stems from DEA action that was taken last month against two Sanford, Fla., CVS stores that were alleged to be among four pharmacy customers of drug distributor Cardinal Health Inc. (CAH) that dispensed the pain drug oxycodone based on bad prescriptions.

The U.S. Court of Appeals for the District of Columbia Circuit on Thursday ruled CVS had "not satisfied the stringent requirements for a stay pending appeal." The decision comes roughly a week after an appeals court said a Cardinal Health distribution hub in Florida can't ship prescription painkillers.

In a prepared statement, CVS said it was "disappointed with today's ruling by the court," saying the company had taken actions that have substantially reduced the amount of oxycodone dispensed at the two Florida pharmacies.

"We remain committed to working with the DEA to do everything we can to reduce prescription drug abuse," CVS said.

-By John Kell, Dow Jones Newswires; 212-416-2480; john.kell@dowjones.com

-Jon Kamp and Timothy Martin of The Wall Street Journal contributed to this article

Stocks mentioned in the article : CVS Caremark Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH CORP
03/24 CVS HEALTH : Offers Private Sector Solutions to America's Health Care Challenges
03/23 CVS HEALTH : Takes Next Step in Five-Year Commitment to Deliver the First Tobacc..
03/23 CVS HEALTH : PBM Clients Achieved Lowest Prescription Drug Trend in Four Years, ..
03/23 CVS HEALTH : Launches Reduced Rx Savings Program to Give Patients Access to More..
03/23 CVS HEALTH : University of Pittsburgh School of Pharmacy and Pittsburgh Public S..
03/23 INSIDER TRADING ACTIVITY CVS HEALTH : CVS) – EVP Sold 23,849 shares of St..
03/21 INSIDER TRADING ACTIVITY CVS HEALTH : CVS) – EVP Sold 6,029 shares of Sto..
03/17 CVS : Driving Affordable Solutions: Reduced Rx Prescription Savings Program
03/16 CVS HEALTH : Oak Paper Products Company, Inc. Appoints New Board Of Directors
03/16 CVS HEALTH : Expands Access to Opioid Overdose-Reversal Drug at CVS Pharmacy loc..
More news
Sector news : Drug Retailers - NEC
02/28 Valeant predicts tough 2017 with revenue to decline
02/16DJRetail CEOs Meet With Trump Over Border Tax Concerns -- Update
02/15DJRetail CEOs Meet With Trump Over Border Tax Concerns
02/14DJEXPRESS SCRIPTS : Revenue Falls
02/14 Exclusive - Trump to meet with retail CEOs on taxes, infrastructure
More sector news : Drug Retailers - NEC
News from SeekingAlpha
03/24 RETIREES : How To Protect The Principal Of Your Dividend Portfolio
03/21 AMERICAN COLLEGE OF CARDIOLOGY : No Repatha Of Glory
03/21 Selling Or Trimming Reasons Within My 86 Stock Portfolio
03/20 10 Dividend Growth Stocks For March 2017
03/14 Triple Threat Investing With CVS
Advertisement
Financials ($)
Sales 2017 184 272 M
EBIT 2017 10 737 M
Net income 2017 5 639 M
Debt 2017 24 998 M
Yield 2017 2,44%
P/E ratio 2017 14,83
P/E ratio 2018 13,28
EV / Sales 2017 0,57x
EV / Sales 2018 0,54x
Capitalization 80 507 M
More Financials
Chart CVS HEALTH CORP
Duration : Period :
CVS Health Corp Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Full-screen chart
Technical analysis trends CVS HEALTH CORP
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 86,5 $
Spread / Average Target 10%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Non-Executive Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH CORP-0.53%80 507
WALGREENS BOOTS ALLIAN..0.25%89 559
EXPRESS SCRIPTS HOLDIN..-6.80%38 486
MCKESSON CORPORATION3.69%30 881
CARDINAL HEALTH INC12.87%25 624
AMERISOURCEBERGEN CORP..10.70%18 808
More Results